Could DNA methylation become a useful measure for multiple myeloma prognoses?

被引：1
作者：
Walker, Brian A. [1 ]
Morgan, Gareth J. [1 ]
机构：
[1] Inst Canc Res, Sect Haematooncol, Sutton SM2 5NG, Surrey, England
来源：
EXPERT REVIEW OF HEMATOLOGY | 2011年 / 4卷 / 02期
关键词：
DNA methylation; MGUS; myeloma; prognosis; MONOCLONAL GAMMOPATHY;
D O I：
10.1586/EHM.11.7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：125 / 127
页数：3
相关论文
共 10 条
  • [1] Ultra High-Risk Myeloma
    Avet-Loiseau, Herve
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2010, : 489 - 493
  • [2] Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context
    Chiecchio, Laura
    Dagrada, Gian Paolo
    Ibrahim, Ashraf H.
    Cabanas, Elizabet Dachs
    Protheroe, Rebecca K. M.
    Stockley, David M.
    Orchard, Kim H.
    Cross, Nicholas C. P.
    Harrison, Christine J.
    Ross, Fiona M.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (12): : 1708 - 1713
  • [3] TGFβR2 aberrant methylation is a potential prognostic marker and therapeutic target in multiple myeloma
    de Carvalho, Fabricio
    Colleoni, Gisele W. B.
    Sampaio Almeida, Manuella S.
    Carvalho, Andre L.
    Vettore, Andre L.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (08) : 1985 - 1991
  • [4] International staging system for multiple myeloma
    Greipp, PR
    San Miguel, J
    Durie, BGM
    Crowley, JJ
    Barlogie, B
    Bladé, J
    Boccadoro, M
    Child, JA
    Harousseau, JL
    Kyle, RA
    Lahuerta, JJ
    Ludwig, H
    Morgan, G
    Powles, R
    Shimizu, K
    Shustik, C
    Sonneveld, P
    Tosi, P
    Turesson, I
    Westin, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) : 3412 - 3420
  • [5] A long-term study of prognosis in monoclonal gammopathy of undetermined significance
    Kyle, RA
    Therneau, TM
    Rajkumar, SV
    Offord, JR
    Larson, DR
    Plevak, MF
    Melton, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (08) : 564 - 569
  • [6] Methylation is an inactivating mechanism of the p16 gene in multiple myeloma associated with high plasma cell proliferation and short survival
    Mateos, MV
    García-Sanz, R
    López-Pérez, R
    Moro, MJ
    Ocio, E
    Hernández, J
    Megido, M
    Caballero, MD
    Fernández-Calvo, J
    Bárez, A
    Almeida, J
    Orfao, A
    González, M
    San Miguel, JF
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (04) : 1034 - 1040
  • [7] Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma
    Walker, Brian A.
    Leone, Paola E.
    Jenner, Matthew W.
    Li, Cheng
    Gonzalez, David
    Johnson, David C.
    Ross, Fiona M.
    Davies, Faith E.
    Morgan, Gareth J.
    [J]. BLOOD, 2006, 108 (05) : 1733 - 1743
  • [8] Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma
    Walker, Brian A.
    Wardell, Christopher P.
    Chiecchio, Laura
    Smith, Emma M.
    Boyd, Kevin D.
    Neri, Antonino
    Davies, Faith E.
    Ross, Fiona M.
    Morgan, Gareth J.
    [J]. BLOOD, 2011, 117 (02) : 553 - 562
  • [9] A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value
    Walker, Brian A.
    Leone, Paola E.
    Chiecchio, Laura
    Dickens, Nicholas J.
    Jenner, Matthew W.
    Boyd, Kevin D.
    Johnson, David C.
    Gonzalez, David
    Dagrada, Gian Paolo
    Protheroe, Rebecca K. M.
    Konn, Zoe J.
    Stockley, David M.
    Gregory, Walter M.
    Davies, Faith E.
    Ross, Fiona M.
    Morgan, Gareth J.
    [J]. BLOOD, 2010, 116 (15) : E56 - E65
  • [10] A monoclonal gammopathy precedes multiple myeloma in most patients
    Weiss, Brendan M.
    Abadie, Jude
    Verma, Pramvir
    Howard, Robin S.
    Kuehl, W. Michael
    [J]. BLOOD, 2009, 113 (22) : 5418 - 5422
1